Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""Benazepril hydrochloride tablets are contraindicated in patients: who are hypersensitive to benazepril or to any other ACE inhibitor with a history of angioedema with or without previous ACE inhibitor treatment Benazepril hydrochloride tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer benazepril hydrochloride tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor [see Warnings and Precautions (5.2) Do not coadminister aliskiren with angiotensin receptor blockers, ACE inhibitors, including benazepril hydrochloride tablets in patients with diabetes [see Drug Interactions (7.4) Angioedema or history of hereditary or idiopathic angioedema ( 4 Hypersensitivity ( 4 Coadministration with aliskiren in patients with diabetes ( 4"" assertion.
- association subject drugbank:DB14125 assertion.
- association predicate treats assertion.
- association object DOID_1558 assertion.
- association relation MedicalContraindication assertion.
- drugbank:DB14125 category Drug assertion.
- DOID_1558 category Disease assertion.
- association provided_by NeuroDKG assertion.